PHARMACY DEPARTMENT: Early Communication About an Ongoing Safety Review Botox and Botox Cosmetic (Botulinum Toxin Type A) and Myobloc (Botulinum Toxin Type B) | Article | NursingCenter

Source:

Plastic and Aesthetic Nursing

July/September 2008, Volume :28 Number 3 , page 150 - 151 [Buy]

Authors

U.S. Food and Drug Administration

FIND YOUR NEXT JOB WITH NURSING JOBSPLUS

© 2024 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer – Your California Privacy Choices -- v09.02.00